June 2023
Volume 64, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2023
Disparities in Systemic Classical and Alternative Pathways in Intermediate Age-Related Macular Degeneration Compared to Geographic Atrophy
Author Affiliations & Notes
  • Alejandro Itzam Marin
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Brandie Wagner
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Jennifer Patnaik
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Felix Poppelaars
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Michael Holers
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Ashley Frazer-Abel
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Niranjan Manoharan
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Marc T Mathias
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Talisa E de Carlo
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Naresh Mandava
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Anne M Lynch
    Ophthalmology, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, United States
  • Footnotes
    Commercial Relationships   Alejandro Marin None; Brandie Wagner None; Jennifer Patnaik Orbits, Code C (Consultant/Contractor), CoCheckKids, Code C (Consultant/Contractor); Felix Poppelaars None; Michael Holers None; Ashley Frazer-Abel None; Niranjan Manoharan Iveric Bio, Code F (Financial Support); Marc Mathias None; Talisa de Carlo None; Naresh Mandava Soma Logic , Code C (Consultant/Contractor), ONL Therapeutics , Code C (Consultant/Contractor), SomaLogix, Code F (Financial Support), 2C Tech, Code I (Personal Financial Interest), Aurea Medical, Code I (Personal Financial Interest), Alcon, Code P (Patent), 2C Tech, Code P (Patent); Anne Lynch None
  • Footnotes
    Support  National Eye Institute of the NIH 32456 (AML), a Research to Prevent Blindness grant to the Department of Ophthalmology, University of Colorado, the Frederic C. Hamilton Macular Degeneration Center, Sue Anschutz-Rogers Eye Center Research Fund, and by NIH/NCATS Colorado CTSA Grant Number UL1 TR002535.
Investigative Ophthalmology & Visual Science June 2023, Vol.64, 2257. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Alejandro Itzam Marin, Brandie Wagner, Jennifer Patnaik, Felix Poppelaars, Michael Holers, Ashley Frazer-Abel, Niranjan Manoharan, Marc T Mathias, Talisa E de Carlo, Naresh Mandava, Anne M Lynch; Disparities in Systemic Classical and Alternative Pathways in Intermediate Age-Related Macular Degeneration Compared to Geographic Atrophy. Invest. Ophthalmol. Vis. Sci. 2023;64(8):2257.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Studies have demonstrated a strong association between the complement system and age-related macular degeneration (AMD). The findings have led to several clinical trials targeting local complement dysregulation in AMD. In addition to complement activation in ocular tissues there is activation systemically. This is understudied. The purpose of our study was to examine differences in plasma levels of systemic complement components in a cross-sectional study of patients with intermediate (iAMD), geographic atrophy (GA), and controls using an extensive panel of complement components from the classical (CP), lectin (LP), and alternative pathway (AP) as well as the regulators factor H and I.

Methods : Patients were drawn from an AMD registry. Diagnosis was confirmed with multimodal imaging and classified using the Beckmann and classification of atrophy criteria. Plasma complement factor levels were measured by ELISA and multiplex Luminex immunoassays. Statistical comparisons between groups were performed using linear regression models on rank-transformed values.

Results : We included 365 patients, of which 206 had iAMD, 96 had GA, and 63 had no AMD (controls). Adjusted for age and multiple comparisons, we found significant dysregulation of many complement components across cases and controls (Table 1). Regarding the AP, median level of Factor B was lower in GA compared to controls and iAMD indicating higher consumption. The C3a/C3 ratio was lower in GA. In terms of the CP, levels of C4 and C2 were higher in GA compared to controls and iAMD. Notably, (Fig 1), we found a stepwise decline in the levels of the major regulators, Factor I and Factor H when comparing each group.

Conclusions : We found substantial changes in levels of systemic complement components when comparing controls and patients with iAMD and GA. Our study demonstrates lower CP consumption associated with GA and supports previous data suggesting higher AP activation is associated with worse AMD. Despite the higher AP consumption, overall complement activity, represented by C3a/C3, remains lower in GA. Our study suggests that there might be a crucial role for the CP in the pathogenesis of AMD and might explain why the response to anti-complement therapy differs among patients with GA.

This abstract was presented at the 2023 ARVO Annual Meeting, held in New Orleans, LA, April 23-27, 2023.

 

Complement levels across groups

Complement levels across groups

 

Boxplot demonstrating systemic levels of Factor I and Factor H across groups

Boxplot demonstrating systemic levels of Factor I and Factor H across groups

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×